<abstract xmlns="http://www.w3.org/1999/xhtml"><sec id="j_joepi-2015-0014_s_001"><h3>Introduction</h3><p>A significant number of patients suffering from epilepsy prove to be resistant to antiepileptic drugs (AEDs). Recent studies, however, suggest that 10–20% of seemingly drug resistant patients may still become seizure-free under the influence of subsequent dosage modifications.</p></sec><sec id="j_joepi-2015-0014_s_002"><h3>Case report</h3><p>We report on a young man with cryptogenic focal epilepsy. He had his first seizure at the age of fifteen. His seizure frequency was decreased during the following 11 years. However, seizure-freedom was never achieved even though he was treated with twelve to fourteen different AEDs during this time. Intensive presurgical evaluations did not allow identification of a surgically remediable focus. Adjunctive treatment with lacosamide 400 mg/day was not successful. However, the patient became seizure-free immediately after an increase of the lacosamide dose up to 500 mg/day. The patient is now seizure-free for more than two years based on a combination of 500 mg lacosamide and 350 mg lamotrigine, followed by 550 mg and 250 mg, respectively.</p></sec><sec id="j_joepi-2015-0014_s_003"><h3>Discussion and conclusion</h3><p>This case report highlights that there is always a chance that modifying the medication can result in a drug-resistant epilepsy patient experiencing a significant reduction of seizures and becoming seizure-free. The decisive step in this example was the off-label prescription of a high dose of lacosamide which the patient tolerated well.</p></sec></abstract>

IntroductionA significant number of patients suffering from epilepsy prove to be resistant to antiepileptic drugs (AEDs). Recent studies, however, suggest that 10–20% of seemingly drug resistant patients may still become seizure-free under the influence of subsequent dosage modifications.Case reportWe report on a young man with cryptogenic focal epilepsy. He had his first seizure at the age of fifteen. His seizure frequency was decreased during the following 11 years. However, seizure-freedom was never achieved even though he was treated with twelve to fourteen different AEDs during this time. Intensive presurgical evaluations did not allow identification of a surgically remediable focus. Adjunctive treatment with lacosamide 400 mg/day was not successful. However, the patient became seizure-free immediately after an increase of the lacosamide dose up to 500 mg/day. The patient is now seizure-free for more than two years based on a combination of 500 mg lacosamide and 350 mg lamotrigine, followed by 550 mg and 250 mg, respectively.Discussion and conclusionThis case report highlights that there is always a chance that modifying the medication can result in a drug-resistant epilepsy patient experiencing a significant reduction of seizures and becoming seizure-free. The decisive step in this example was the off-label prescription of a high dose of lacosamide which the patient tolerated well.

Successful treatment with adjunctive lacosamide in a patient with long term “drug resistant” focal epilepsy

Journal of Epileptology

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

IntroductionA significant number of patients suffering from epilepsy prove to be resistant to antiepileptic drugs (AEDs). Recent studies, however, suggest that...

Successful treatment with adjunctive lacosamide in a patient with long term “drug resistant” focal epilepsy

Pubblicato online: 11 mar 2014

Pagine: 51 - 55

Ricevuto: 11 feb 2014

Accettato: 05 mar 2014

DOI: https://doi.org/10.21307/joepi-2015-0014

Parole chiave
epilepsy, drug resistance, lacosamide

© 2014 Walter Fröscher et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Successful treatment with adjunctive lacosamide in a patient with long term “drug resistant” focal epilepsy

Pubblicato online: 11 mar 2014

Pagine: 51 - 55

Ricevuto: 11 feb 2014

Accettato: 05 mar 2014

DOI: https://doi.org/10.21307/joepi-2015-0014

Parole chiaveepilepsy, drug resistance, lacosamide

© 2014 Walter Fröscher et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Parole chiave
epilepsy, drug resistance, lacosamide